Lorvotuzumab (Anti-NCAM1 / CD56)

Ask supplier a question | View on supplier's website

Lorvotuzumab (Anti-NCAM1 / CD56) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine. MW: 145.5 kD.

Supplier	Selleck Chemicals
Product #	A2393
Sku #	A2393-1mg*25
Pricing	1mg*25, $4170.00

Feedback